Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Delayed Quote CAD

RAMM Pharma Corp. (RAMM.CN)

Compare
0.0150
0.0000
(0.00%)
At close: April 1 at 12:51:18 PM EDT
Loading Chart for RAMM.CN
  • Previous Close 0.0150
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0150 - 0.0150
  • 52 Week Range 0.0050 - 0.0650
  • Volume 0
  • Avg. Volume 16,159
  • Market Cap (intraday) 1.791M
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1300
  • Earnings Date Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.

www.wearerammpharma.com

--

Full Time Employees

October 31

Fiscal Year Ends

Recent News: RAMM.CN

View More

Performance Overview: RAMM.CN

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

RAMM.CN
0.00%
S&P/TSX Composite index (^GSPTSE)
1.74%

1-Year Return

RAMM.CN
75.00%
S&P/TSX Composite index (^GSPTSE)
11.71%

3-Year Return

RAMM.CN
93.48%
S&P/TSX Composite index (^GSPTSE)
10.69%

5-Year Return

RAMM.CN
96.47%
S&P/TSX Composite index (^GSPTSE)
68.47%

Compare To: RAMM.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RAMM.CN

View More

Valuation Measures

As of 4/17/2025
  • Market Cap

    1.79M

  • Enterprise Value

    1.51M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.41

  • Price/Book (mrq)

    0.14

  • Enterprise Value/Revenue

    0.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.67%

  • Return on Equity (ttm)

    -75.84%

  • Revenue (ttm)

    4.4M

  • Net Income Avi to Common (ttm)

    -15.23M

  • Diluted EPS (ttm)

    -0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    480.44k

  • Total Debt/Equity (mrq)

    1.59%

  • Levered Free Cash Flow (ttm)

    -2.21M

Research Analysis: RAMM.CN

View More

People Also Watch